Strs Ohio Athira Pharma, Inc. Transaction History

Strs Ohio

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 26, 2021	SELL	$10.24 - $20.87 $384,000 - $782,625	-37,500 Closed	0 $0
Q1 2021 Apr 23, 2021	BUY	$16.9 - $29.77 $581,360 - $1.02 Million	34,400 Added 1109.68%	37,500 $690,000
Q4 2020 Jan 25, 2021	BUY	$16.48 - $34.3 $51,088 - $106,329	3,100 New	3,100 $106,000

16.9M

112K

68K

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $24.2M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.